Nordwand Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-400
| Closed | -$29.4K | – | 177 |
|
|
2025
Q1 | $29.4K | Hold |
400
| – | – | 0.01% | 59 |
|
|
2024
Q4 | $26.2K | Hold |
400
| – | – | 0.01% | 64 |
|
|
2024
Q3 | $31.2K | Hold |
400
| – | – | 0.01% | 63 |
|
|
2024
Q2 | $31.2K | Hold |
400
| – | – | 0.01% | 80 |
|
|
2024
Q1 | $27.1K | Sell |
400
-178
| -31% | -$12.1K | 0.01% | 96 |
|
|
2023
Q4 | $38.9K | Buy |
578
+178
| +45% | +$12K | 0.01% | 75 |
|
|
2023
Q3 | $27.1K | Hold |
400
| – | – | 0.01% | 75 |
|
|
2023
Q2 | $28.6K | Hold |
400
| – | – | ﹤0.01% | 73 |
|
|
2023
Q1 | $27.8K | Sell |
400
-20,086
| -98% | -$1.39M | ﹤0.01% | 78 |
|
|
2022
Q4 | $1.39M | Buy |
+20,486
| New | +$1.39M | 0.17% | 33 |
|